Medicare Enrolled
Dr. Li Ge, MD
Medical Oncology · Fresno, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Mixed engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ge from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ge?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ge
Dr. Li Ge is a medical oncology specialist in Fresno, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Ge performed 67,087 Medicare services across 3,016 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ge received a total of $15,918 from 38 pharmaceutical and/or device companies across 343 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ge is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 8% volume in CA
$15,918 industry payments
Medicare Practice Summary
Medicare Utilization ↗67,087
Medicare services
Top 8% in CA for medical oncology
3,016
Unique beneficiaries
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~3,354 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Paclitaxel chemotherapy injection | 27,642 | $0 | $10 |
| Denosumab injection (Prolia/Xgeva) | 11,580 | $18 | $60 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
7,950 | $0 | $13 |
| Trastuzumab-dttb biosimilar injection, 10 mg An injection of trastuzumab-dttb, a biosimilar medication, administered in a 10 mg dose. |
3,744 | $41 | $240 |
| Anti-nausea injection (Aloxi/palonosetron) | 3,210 | $1 | $80 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,849 | $0 | $10 |
| Trastuzumab-dkst biosimilar injection, 10 mg This code represents the administration of a 10 mg dose of trastuzumab-dkst, a biosimilar medication. It covers the injection of this specific pharmaceutical product. |
1,746 | $33 | $182 |
| Injection, fulvestrant (teva) not therapeutically equivalent to j9395, 25 mg | 1,700 | $12 | $34 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
839 | $99 | $405 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
720 | $8 | $32 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
683 | $8 | $23 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
594 | $10 | $43 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
421 | $25 | $101 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
419 | $110 | $468 |
| Injection, fulvestrant, 25 mg | 380 | $9 | $145 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
325 | $13 | $60 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
323 | $1 | $10 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
237 | $1 | $23 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
236 | $29 | $104 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
231 | $19 | $77 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 230 | $20 | $85 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
210 | $12 | $69 |
| Virtual check-in for established patient A brief communication service provided by a qualified healthcare professional to an established patient via technology, such as a virtual check-in. |
119 | $12 | $50 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
104 | $55 | $227 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
102 | $63 | $285 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
84 | $6 | $212 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
57 | $128 | $521 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
56 | $53 | $232 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
50 | $149 | $564 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
43 | $6 | $27 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
30 | $13 | $47 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
30 | $14 | $44 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
29 | $15 | $45 |
| Iron level test | 26 | $6 | $26 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
23 | $1 | $10 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 125 | 22 | $20 | $85 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
22 | $10 | $44 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
21 | $24 | $99 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.5% high complexity
92.3% medium
6.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$15,918
Total received (2018-2024)
Avg $2,653/year across 6 years
Top 33% in CA for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
38
Companies
343
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,811 (49.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$7,604 (47.8%)
Other
Charitable contributions, space rental, and other categories
$503 (3.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,464
2023
$2,019
2022
$8,826
2021
$1,093
2019
$146
2018
$1,370
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$503
AstraZeneca Pharmaceuticals LP
$379
Gilead Sciences, Inc.
$379
Lilly USA, LLC
$244
PFIZER INC.
$221
Genentech USA, Inc.
$189
TerSera Therapeutics LLC
$144
PUMA BIOTECHNOLOGY, INC.
$109
Daiichi Sankyo Inc.
$92
Fresenius Kabi USA, LLC
$28
Stemline Therapeutics Inc.
$28
ABBVIE INC.
$25
Myriad Genetic Laboratories, Inc.
$25
Becton, Dickinson and Company
$24
Eisai Inc.
$22
Celgene Corporation
$20
ImmunoGen, Inc.
$15
Azurity Pharmaceuticals, Inc.
$15
Top 3 companies account for 51.2% of 2024 payments
All-time payments by company (2018-2024) ›
Gilead Sciences, Inc.
$8,357
Roche Products Limited
$1,370
Daiichi Sankyo Inc.
$1,138
AstraZeneca Pharmaceuticals LP
$800
Novartis Pharmaceuticals Corporation
$757
Eisai Inc.
$582
Lilly USA, LLC
$513
PFIZER INC.
$383
Myriad Genetic Laboratories, Inc.
$240
Seagen Inc.
$224
Genentech USA, Inc.
$212
TerSera Therapeutics LLC
$182
Blueprint Medicines Corporation
$122
GlaxoSmithKline, LLC.
$110
PUMA BIOTECHNOLOGY, INC.
$109
Array BioPharma Inc.
$96
ImmunoGen, Inc.
$80
Coherus Biosciences Inc.
$61
SOBI, INC
$54
Stemline Therapeutics Inc.
$54
Mylan Institutional Inc.
$46
EISAI INC.
$45
Merck Sharp & Dohme Corporation
$42
Puma Biotechnology, Inc.
$34
GENZYME CORPORATION
$31
Merck Sharp & Dohme LLC
$30
Fresenius Kabi USA, LLC
$28
Pharmacosmos Therapeutics Inc.
$26
ABBVIE INC.
$25
Becton, Dickinson and Company
$24
Dova Pharmaceuticals
$22
Ipsen Biopharmaceuticals, Inc
$22
Celgene Corporation
$20
Boehringer Ingelheim Pharmaceuticals, Inc.
$20
Azurity Pharmaceuticals, Inc.
$15
Heron Therapeutics, Inc.
$15
Cumberland Pharmaceuticals, Inc.
$15
Foundation Medicine, Inc.
$13
Top 3 companies account for 68.3% of all-time payments
Associated products mentioned in payments ›
ARISTA AH FlexiTip · BRACANALYSIS CDX · Braftovi · CABLIVI · Doptelet · ELAHERE · ENHERTU · Elahere · Enhertu · FOUNDATIONONE LIQUID CDX · GAVRETO · Halaven · IBRANCE · INJECTAFER · Itovebi · KEYTRUDA · KISQALI · LYNPARZA · Lenvima · MONOFERRIC · MYCHOICE CDX · MYRISK · NERLYNX · OGIVRI · Orserdu · PIQRAY · Perjeta · Phesgo · Pomalyst · Quzyttir · SANCUSO · SCEMBLIX · SOMATULINE DEPOT · SUSTOL · Stimufend · TASIGNA · TECENTRIQ · TUKYSA · Trodelvy · Udenyca · VERZENIO · VIVIMUSTA · ZEJULA · Zoladex · myChoice CDx
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (49%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Medical oncologists within 10 mi
4
Per 100K population
0.4
County median income
$71,434
Nearest hospital
FRESNO SURGICAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Ge is a mixed practice specialist, with above-average Medicare volume (top 8% in CA), with mixed engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Ge experienced with paclitaxel chemotherapy injection?
Based on Medicare claims data, Dr. Ge performed 27,642 paclitaxel chemotherapy injection services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ge receive payments from pharmaceutical companies?
Yes. Dr. Ge received a total of $15,918 from 38 companies across 343 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ge's costs compare to other medical oncologists in Fresno?
Dr. Ge's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ge) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in Fresno
Browse medical oncologists in Fresno ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in CA
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in CA
Which CA medical oncologists receive the most from drug and device companies.
By company
Gilead Sciences, Inc. Payments to Doctors
See all physicians who received payments from Gilead Sciences, Inc.
By company
Roche Products Limited Payments to Doctors
See all physicians who received payments from Roche Products Limited.
By company
Daiichi Sankyo Inc. Payments to Doctors
See all physicians who received payments from Daiichi Sankyo Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology